Point72 Hong Kong’s GH Research GHRS Stock Holding History

Point72 Hong Kong’s Portfolio GHRS Stock Details GHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-80	Closed	-$1K	–	2098
2022 Q2	$1K	Hold	80	–	–	﹤0.01%	1813
2022 Q1	$1K	Buy	+80	New	+$1.41K	﹤0.01%	1753

Other funds holding GHRS

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Hong Kong's GHRS Position: Q3 2022 in Review

Point72 Hong Kong sold out of GH Research (GHRS) in Q3 2022, closing a stake of 80 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in GHRS in Q1 2022 and held it in 2 quarters. The position peaked at $1K in Q2 2022. 34 funds tracked by Wall St. Rank hold GHRS as of Q3 2022.

Point72 Hong Kong reported no remaining GH Research position as of Q3 2022 after selling out during the quarter.
Point72 Hong Kong sold 80 GH Research shares in Q3 2022, an estimated $1K.
Point72 Hong Kong first reported a position in GH Research in Q1 2022 and held it in 2 quarters.
Point72 Hong Kong's GH Research position peaked at $1K in Q2 2022.
34 funds tracked by Wall St. Rank held GH Research as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.